Our Companies

kannalife sciences laboratory

Our Accomplishments

› First with a license to commercialize the ‘507 patent “Cannabinoids as Antioxidants and Neuroprotectants”. Read More.

› Holds exclusive licenses from the NIH to develop cannabinoid-based treatments for hepatic encephalopathy and chronic traumatic encephalopathy.

› Developed a synthetic molecule related to cannabidiol called KLS-13019, which is 50 times more potent and 400 times less toxic than naturally occurring cannabidiol. Read More.


Latest Kannalife™ Sciences News

CNBC, Verdict, Seeking Alpha, and More Feature News from Medical Marijuana, Inc.

Read more

Kannalife Sciences Spokesman Nick Lowery Talks About Efforts to Develop CTE Treatment with Reiter Than You

Read more

Listen: KC’s Between the Lines Radio Welcomes Home Kannalife Sciences Spokesman Nick Lowery to Discuss Benefits of CBD for CTE

Read more
See more

[button size=”medium_rd_bt” radius=”0″ url=”/companies/kannalife/” position=”ta_center” ex_class=”company-of-firsts-btn”]OVERVIEW[/button][button size=”medium_rd_bt” radius=”0″ url=”/kannalife/news-press/” position=”ta_center” ex_class=”company-of-firsts-btn”]NEWS & PRESS[/button][button size=”medium_rd_bt” radius=”0″ url=”/kannalife/leadership/” position=”ta_center” ex_class=”company-of-firsts-btn”]LEADERSHIP[/button][button size=”medium_rd_bt” radius=”0″ url=”/kannalife/brands/” position=”ta_center” ex_class=”company-of-firsts-btn”]AREAS OF FOCUS[/button][button size=”medium_rd_bt” radius=”0″ url=”/kannalife/contact/” position=”ta_center” ex_class=”company-of-firsts-btn”]CONTACT[/button]